Company intelligence / Profile preview
Pluri Inc.
Haifa, Israelpluri-biotech.com ↗
- Ownership
- Public · PLUR
- Employees
- ~180
- Development stage
- Other
01
Overview
Pluri Inc. develops proprietary platforms to manufacture scalable cell-based products using a patented 3D expansion system. The company’s core expertise lies in human placental adherent stromal cells for regenerative medicine but has expanded into agricultural biotechnology (PluriAgtech) and food technology (e.g., developing cell-cultured coffee). In January 2024, it launched a CDMO division to provide contract development/manufacturing services for the growing global market of advanced therapies. The company operates GMP-certified facilities supporting both its own pipeline and external partnerships. Recent years have seen diversification beyond traditional biotech into sustainability-focused sectors like agri-food tech.[1][2][3][4]
- Therapeutic areas
- Other
- Modalities
- Cell-based therapies (placental adherent stromal cells)cell expansion technology; also applies to cell-based products in food and agriculture[2][4].
- Industry
- Biotech
02
Drug pipeline
12 assets11 more assets in the full pipeline.
03
Partnerships
Not specifically listed by name; ongoing negotiations with multiple biotech clients via the CDMO arm are mentioned.[4]
04
Financials
- Market cap
- $12.8M
- Total revenue
- $1M
- Enterprise value
- $39.9M
Beyond the preview
Go deeper on Pluri Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pluri Inc..